Overview

Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2018-07-19
Target enrollment:
Participant gender:
Summary
This is an Open-label Study to Assess the Safety of Repeat Dose of FX006 Administered to Patients with Osteoarthritis (OA) of the Knee
Phase:
Phase 3
Details
Lead Sponsor:
Flexion Therapeutics, Inc.
Treatments:
FX006